Related Experiment Video
Updated: Aug 17, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Modifications in the regression of the acute inflammation caused by a beta-adrenergic effect unbalanced by the
Abstract:
A biased beta-adrenergic effect was produced either by blocking the alpha-adrenergic component of endogenous catecholamines using phentolamine or by application of isoproterenol. Both experimental conditions led to a prolongation of the lymphocyte phase of the inflammatory process. A beta-bias also curbed the activity of a substance (or substances) inhibiting the ingress of lymphocytes into the site of inflammation (subcutaneously injected Sephadex) around the fourth and fifth day after the onset of inflammation. This lack in activity is evidently connected with the prolonged lymphocyte phase.
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Types of β-Blockers

